Table 5.

Association of K359R (rs1331232028) SNP with Metastatic State and Stage of Ovarian Cancer Patients.

Genotyping Distribution of rs1331232028 SNPs’ Clinical Features
	Metastatic State						Cancer’s Stage
Genotype	Metastatic			Non-Metastatic			Stage I-II			Stage III-IV
	OR	RR	p Value	OR	RR	p Value	OR	RR	p Value	OR	RR	p Value
	(95% CI)	(95% CI)		(95% CI)	(95% CI)		(95% CI)	(95% CI)		(95% CI)	(95% CI)
AA	0.41	0.52	0.0017	1.32	1.18	0.59	5.19	3.19	0.0065	1.58	1.30	0.44
	(0.13–1.20)	(0.22–1.14)		(0.43–3.55)	(0.60–2.09)		(1.53–16.89)	(1.42–7.12)		(0.61–4.08)	(0.71–2.17)
AG	0.66	0.73	0.76	1.530	1.297	0.45	0.81	0.85	>0.99	1.38	1.21	0.62
	(0.21–2.28)	(0.27–1.72)		(0.55–4.04)	(0.71–2.23)		(0.25–2.99)	(0.31–2.07)		(0.51–3.57	(0.67–2.06)
GG	6.23	3.503	0.12	0.5567	0.6885	0.25	0.20	0.28	0.02	0.43	0.59	0.11
	(2.01–19.43)	(1.62–7.63)		(0.21–1.46)	(0.37–1.22		(0.05–0.78)	(0.09–0.81)		(0.18–1.13	(0.31–1.05)